ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilization

• DOI: 10.1007/s12350-019-01761-5
• Publication Date: 2019-08-29T16:07:48Z
• Authors: Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H. Falk; Victor A. Ferrari; Marianna Fontana; Olivier Gheysens; Julian D. Gillmore; Andor W.J.M. Glau...; Mazen A. Hanna; Bouke P.C. Hazenberg; Arnt V. Kristen; Raymond Y. Kwong; Mathew S. Maurer; Giampaolo Merlini; Edward J. Miller; James C. Moon; Venkatesh L. Murthy; C. Cristina Quarta; Claudio Rapezzi; Frederick L. Ruberg; Sanjiv J. Shah; Riemer H.J.A. Slart; Hein J. Verberne; Jamieson M. Bourque
• Keywords: Delphi Technique; diagnosis; Biopsy; Expert consensus; Appropriate use; Multimodal Imaging; 0302 clinical medicine; Diagnosis; MAGNETIC-RESONANCE; Societies, Medical; Multimodality; CARDIOLOGY; expert consensus; Evidence-Based Medicine; American Heart Association; Amyloidosis; *American Heart Association; Prognosis; Magnetic Resonance Imaging; Molecular Imaging; 3. Good health; AHA Scientific Statements; BRAIN NATRIURETIC PEPTIDE; Echocardiography; HEART-FAILURE; Cardiomyopathies; Consensus; LIGHT-CHAIN AMYLOIDOSIS; Clinical Decision-Making; Cardiology; 610; Magnetic Resonance Imaging, Cine; AHA Scientific Statements; appropriate use; cardiac amyloidosis; diagnosis; expert consensus; multimodality; Cardiac amyloidosis; AMERICAN-COLLEGE; DIAGNOSIS; 03 medical and health sciences; Predictive Value of Tests; Humans; ASSOCIATION TASK-FORCE; Radionuclide Imaging; multimodality; appropriate use; Heart Failure; Appropriate use; Cardiac amyloidosis; Diagnosis; Expert consensus; Multimodality; Myocardium; cardiac amyloidosis; STAGING SYSTEM; United States; AL; Nuclear Medicine; Tomography, X-Ray Computed; TASK-FORCE

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.